Effects of sleep deprivation on nocturnal cytokine concentrations in depressed patients and healthy control subjects

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 3, 2012, Pages 354-366

  Voderholzer, Ulrich ^a,c   Fiebich, Bernd L ^a   Dersch, Rick ^a   Feige, Bernd ^a   Piosczyk, Hannah ^a   Kopasz, Marta ^a   Riemann, Dieter ^a   Lieb, Klaus ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c Medical Psychosomatic Clinic Roseneck   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6;

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP DEPRIVATION;

EID: 84867590879     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11060142     Document Type: Article

References (62)

1. Adler UC, Marques AH, Calil HM: Inflammatory aspects of depression. Inflamm Allergy Drug Targets 2008; 7:19-23
2. Elenkov IJ, Iezzoni DG, Daly A, et al: Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005; 12:255-269
3. Irwin MR, Miller AH: Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007; 21:374-383
4. Maes M, Bosmans E, Meltzer HY: Immunoendocrine aspects of major depression: relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 1995; 245:172-178
5. Sluzewska A, Rybakowski J, Bosmans E, et al: Indicators of immune activation in major depression. Psychiatry Res 1996; 64:161-167
6. Frommberger UH, Bauer J, Haselbauer P, et al: Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 1997; 247:228-233
7. Maes M, Bosmans E, De Jongh R, et al: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997; 9:853-858
8. Leu SJ, Shiah IS, Yatham LN, et al: Immune-inflammatory markers in patients with seasonal affective disorder: effects of light therapy. J Affect Disord 2001; 63:27-34
9. Maes M, Meltzer HY, Bosmans E, et al: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995; 34:301-309
10. Cyranowski JM, Marsland AL, Bromberger JT, et al: Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav Immun 2007; 21:229-237
11. Haack M, Hinze-Selch D, Fenzel T, et al: Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999; 33:407-418
12. Kagaya A, Kugaya A, Takebayashi M, et al: Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 2001; 43:59-62
13. Howren MB, Lamkin DM, Suls J: Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71:171-186
14. Gür A, Karakoç M, Nas K, et al: Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002; 29:358-361
15. Kanba S, Manki H, Shintani F, et al: Aberrant interleukin-2 receptor-mediated blastoformation of peripheral blood lymphocytes in a severe major depressive episode. Psychol Med 1998; 28:481-484
16. Ovaskainen Y, Koponen H, Jokelainen J, et al: Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males. Psychiatry Res 2009; 15;167(1-2):73-79
17. Pollmächer T, Haack M, Schuld A, et al: Low levels of circulating inflammatory cytokines: do they affect human brain functions? Brain Behav Immun 2002; 16:525-532
18. Irwin MR, Wang M, Campomayor CO, et al: Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006; 166:1756-1762
19. Vgontzas AN, Zoumakis E, Lin HM, et al: Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004; 89:4409-4413
20. Shearer WT, Reuben JM, Mullington JM, et al: Soluble TNFalpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001; 107:165-170
21. Gundersen Y, Opstad PK, Reistad T, et al: Seven days' around the clock exhaustive physical exertion combined with energy depletion and sleep deprivation primes circulating leukocytes. Eur J Appl Physiol 2006; 97:151-157
22. Frey DJ, Fleshner M, Wright KP Jr: The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain Behav Immun 2007; 21:1050-1057
23. Benedetti F, Lucca A, Brambilla F, et al: Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26:1167-1170
24. Lanquillon S, Krieg JC, Bening-Abu-Shach U, et al: Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22:370-379
25. Mikova O, Yakimova R, Bosmans E, et al: Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001; 11: 203-208
26. Wu JC, Bunney WE: The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 1990; 147:14-21
27. Wirz-Justice A, Van den Hoofdakker RH: Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry 1999; 46:445-453
28. Voderholzer U, Al-Shajlawi A, Weske G, et al: Are there gender differences in objective and subjective sleep measures? a study of insomniacs and healthy controls. Depress Anxiety 2003; 17:162-172
29. Voderholzer U, Hornyak M, Thiel B, et al: Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 1998; 18:112-124
30. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
31. Hu J, Chen Z, Gorczynski CP, et al: Sleep-deprived mice show altered cytokine production manifest by perturbations in serum IL-1ra, TNFa, and IL-6 levels. Brain Behav Immun 2003; 17:498-504
32. Yehuda S, Sredni B, Carasso RL, et al: REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. J Interferon Cytokine Res 2009; 29:393-398
33. Everson CA: Clinical assessment of blood leukocytes, serum cytokines, and serum immunoglobulines as responses to sleep deprivation in laboratory rats. AmJ Physiol Regul Integr Comp Physiol 2005; 289:1054-1063
34. Voderholzer U, Hohagen F, Klein T, et al: Impact of sleep deprivation and subsequent recovery sleep on cortisol in unmedicated depressed patients. Am J Psychiatry 2004; 161:1404-1410
35. Haack M, Kraus T, Schuld A, et al: Diurnal variations of interleukin-6 plasma levels are confounded by blood-drawing procedures. Psychoneuroendocrinology 2002; 27:921-931
36. Vgontzas AN, Bixler EO, Lin HM, et al: IL-6 and its circadian secretion in humans. Neuroimmunomodulation 2005; 12:131-140
37. Dinges DF, Douglas SD, Hamarman S, et al: Sleep deprivation and human immune function. Adv Neuroimmunol 1995; 5: 97-110
38. Born J, Lange T, Hansen K, et al: Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997; 158:4454-4464
39. Vgontzas AN, Papanicolaou DA, Bixler EO, et al: Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 1999; 84:2603-2607
40. Redwine L, Hauger RL, Gillin JC, et al: Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab 2000; 85:3597-3603
41. Vgontzas AN, Pejovic S, Zoumakis E, et al: Hypothalamicpituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2007; 92:4199-4207
42. Moldofsky H, Lue FA, Davidson JR, et al: Effects of sleep deprivation on human immune functions. FASEB J 1989; 3: 1972-1977
43. Leonard B: Stress, depression and the activation of the immune system. World J Biol Psychiatry 2000; 1:17-25
44. Bøyum A, Wiik P, Gustavsson E, et al: The effect of strenuous exercise, calorie deficiency, and sleep deprivation on white blood cells, plasma immunoglobulins and cytokines. Scand J Immunol 1996; 43:228-235
45. Lieb K, Biersack L, Waschbisch A, et al: Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373MG astrocytoma cells. JNeurochem2005; 93:549-559
46. Batistaki C, Kostopanagiotou G, Myrianthefs P, et al: Effect of exogenous catecholamines on tumor necrosis factor alpha, interleukin-6, interleukin-10, and beta-endorphin levels following severe trauma. Vascul Pharmacol 2008; 48:85-91
47. Papanicolaou DA, Petrides JS, Tsigos C, et al: Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996; 271: E601-E605
48. Turnbull AV, Rivier C: Regulation of the HPA axis by cytokines. Brain Behav Immun 1995; 9:253-275
49. Lieb K, Kaltschmidt C, Kaltschmidt B, et al: Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373. J Neurochem 1996; 66:1496-1503
50. Bauer J, Ganter U, Geiger T, et al: Regulation of interleukin-6 expression in cultured human blood monocytes and monocytederived macrophages. Blood 1988; 72:1134-1140
51. Helle M, Boeije L, Pascual-Salcedo D, et al: Differential induction of interleukin-6 production by monocytes, endothelial cells and smooth muscle cells. Prog Clin Biol Res 1991; 367:61-71
52. Zhou D, Shanks N, Riechman SE, et al: Interleukin 6 modulates interleukin-1-and stress-induced activation of the hypothalamicpituitary-adrenal axis in male rats. Neuroendocrinology 1996; 63:227-236
53. Späth-Schwalbe E, Hansen K, Schmidt F, et al: Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 1998; 83:1573-1579
54. Päth G, Scherbaum WA, Bornstein SR: The role of interleukin-6 in the human adrenal gland. Eur J Clin Invest 2000; 30(Suppl 3):91-95
55. Rothwell NJ, Luheshi G, Toulmond S: Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol Ther 1996; 69:85-95
56. Vgontzas AN, Bixler EO, Chrousos GP: Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann N Y Acad Sci 2006; 1083:329-344
57. Vgontzas AN, ZoumakisM, Bixler EO, et al: Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 2003; 88:2087-2095
58. Vgontzas AN, Zoumakis E, Bixler EO, et al: Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004; 89: 2119-2126
59. Gundersen Y, Opstad PK, Reistad T, et al: Seven days' around the clock exhaustive physical exertion combined with energy depletion and sleep deprivation primes circulating leukocytes. Eur J Appl Physiol 2006; 97:151-157
60. Miller DB, O'Callaghan JP: Depression, cytokines, and glial function. Metabolism 2005; 54(Suppl 1):33-38
61. Miller AH, Maletic V, Raison CL: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65:732-741
62. Miller AH: Mechanisms of cytokine-induced behavioural changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 2009; 23:149-158